首页> 美国卫生研究院文献>Gut >Comparison of the oral (PABA) pancreatic function test the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.
【2h】

Comparison of the oral (PABA) pancreatic function test the secretin-pancreozymin test and endoscopic retrograde pancreatography in chronic alcohol induced pancreatitis.

机译:慢性酒精性胰腺炎的口服(PABA)胰腺功能测试促胰液素-胰酶测试和内镜逆行胰成像的比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The oral (PABA) pancreatic function test (PFT), the secretin-pancreozymin test and endoscopic retrograde pancreatography (ERCP) have been carried out in 32 patients with suspected chronic alcohol induced pancreatitis (CAIP) in order to evaluate which, if any, test was most likely to confirm the provisional diagnosis. Thirty one patients had changes of minimal (n = 6) moderate (n = 7) or advanced (n = 18) chronic pancreatitis on pancreatography, whilst one patient had a pancreas divisum. Eight hour urinary PABA excretion was significantly reduced in patients with moderate and advanced structural changes (p less than 0.001) and correlated significantly with all parameters of the PFT, although eight patients with an abnormal pancreatogram and pancreatic function test had a normal PABA value. The PFT was abnormal in 23 patients, but normal in five patients with an abnormal pancreatogram and low PABA value. Most patients with minimal change pancreatitis had a normal PABA test and PFT. We conclude that pancreatography appears to be the most sensitive method for detecting chronic pancreatic damage and for confirming a clinical diagnosis of chronic alcohol induced pancreatitis. Both the PFT and PABA test are useful confirmatory tests and whilst the PFT is slightly more sensitive for assessing pancreatic exocrine function, the PABA test is well tolerated and simple to perform. It may therefore be the complementary investigation of choice for this group of patients.
机译:已对32名疑似慢性酒精诱发的胰腺炎(CAIP)患者进行了口服(PABA)胰腺功能测试(PFT),促胰液素-胰酶原测试和内镜逆行胰腺造影(ERCP),以评估是否进行了测试最有可能确认临时诊断。胰腺成像检查中有31例患者出现轻度(n = 6)中度(n = 7)或晚期(n = 18)慢性胰腺炎变化,而1例患者则患有胰脏分裂。具有中度和晚期结构改变的患者的8小时尿PABA排泄显着减少(p小于0.001),并且与PFT的所有参数均显着相关,尽管有8位胰腺图和胰腺功能检查异常的患者的PABA值正常。 PFT异常23例,但5例正常,胰腺异常且PABA值低。大多数胰腺炎最小变化患者的PABA测试和PFT正常。我们得出的结论是,胰腺造影似乎是检测慢性胰腺损害和确认慢性酒精性胰腺炎的临床诊断的最灵敏方法。 PFT和PABA测试均是有用的验证性测试,尽管PFT对评估胰腺外分泌功能的敏感性稍高,但PABA测试的耐受性良好且操作简便。因此,这可能是该组患者选择的补充研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号